Priorities of cancer research in Nepal

Dr Soniya Dulal - BP Koirala Institute of Health Sciences, Dharan, Nepal
Priorities of cancer research in Nepal ( Dr Soniya Dulal - BP Koirala Institute of Health Sciences, Dharan, Nepal )
20 Oct 2020

OncoAlert and ecancer weekly roundup for August 17-23 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for August 17-23 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
24 Aug 2020

OncoAlert and ecancer weekly roundup for August 1-8 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for August 1-8 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
17 Aug 2020

CaRE2 Cancer Research Link© : Pancreatic Cancer Disparities featuring Prof Jose Trevino

Prof Folakemi Odedina and Prof Jose Trevino
CaRE2 Cancer Research Link© : Pancreatic Cancer Disparities featuring Prof Jose Trevino ( Prof Folakemi Odedina and Prof Jose Trevino )
11 Aug 2020

CheckMate 459: Long-term survival outcomes with nivolumab versus sorafenib as first-line treatment in aHCC

Prof Bruno Sangro - University of Navarra, Pamplona, Spain
CheckMate 459: Long-term survival outcomes with nivolumab versus sorafenib as first-line treatment in aHCC ( Prof Bruno Sangro - University of Navarra, Pamplona, Spain )
15 Jul 2020

Phase I/II results: First-line NALIRIFOX in patients with pancreatic ductal adenocarcinoma

Dr Zev Wainberg - Ronald Reagan UCLA Medical Center, Los Angeles, USA
Phase I/II results: First-line NALIRIFOX in patients with pancreatic ductal adenocarcinoma ( Dr Zev Wainberg - Ronald Reagan UCLA Medical Center, Los Angeles, USA )
8 Jul 2020

Early safety from a trial of talimogene laherparepvec (T-VEC) injected into liver tumours plus pembrolizumab

Prof J. Randy Hecht - UCLA Jonsson Comprehensive Cancer Center, Santa Monica, USA
Early safety from a trial of talimogene laherparepvec (T-VEC) injected into liver tumours plus pembrolizumab ( Prof J. Randy Hecht - UCLA Jonsson Comprehensive Cancer Center, Santa Monica, USA )
17 Jun 2020

Perioperative chemotherapy with mFOLFIRINOX vs gemcitabine/nab-paclitaxel for resectable pancreatic ductal adenocarcinoma

Prof Davendra Sohal - University of Cincinnati, Cincinnati, USA
Perioperative chemotherapy with mFOLFIRINOX vs gemcitabine/nab-paclitaxel for resectable pancreatic ductal adenocarcinoma ( Prof Davendra Sohal - University of Cincinnati, Cincinnati, USA )
15 Jun 2020

Checkpoint inhibitors for the treatment of advanced hepatocellular carcinoma

Dr Katie Kelley - University of California San Francisco, San Francisco, USA
Checkpoint inhibitors for the treatment of advanced hepatocellular carcinoma ( Dr Katie Kelley - University of California San Francisco, San Francisco, USA )
12 Jun 2020

Highlights from ASCO 2020

Dr Bishal Gyawali - Queen's University, Kingston, Canada
Highlights from ASCO 2020 ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
5 Jun 2020

The potential of KRAS inhibitors for non-small-cell lung cancer

Prof Reinhard Büttner - University Hospital Cologne, Cologne, Germany
The potential of KRAS inhibitors for non-small-cell lung cancer ( Prof Reinhard Büttner - University Hospital Cologne, Cologne, Germany )
22 Apr 2020

NIVOREN: Nivolumab in a 'real world setting' for metastatic clear-cell renal cell carcinoma

Dr Yann-Alexandre Vano - Hôpital Européen Georges-Pompidou, Paris, France
NIVOREN: Nivolumab in a 'real world setting' for metastatic clear-cell renal cell carcinoma ( Dr Yann-Alexandre Vano - Hôpital Européen Georges-Pompidou, Paris, France )
18 Feb 2020